Predictors for weight loss after Roux-en-Y gastric bypass: the trend and associated factors for weight loss

Abstract Background Historically, Roux-en-Y gastric bypass (RYGB) has been considered the gold standard of bariatric surgery (BS). This procedure acts as a mixed restrictive and malabsorptive operation. Methods  This retrospective cohort study included 410 morbidly obese patients (BMI > 40 kg/m 2...

Full description

Saved in:
Bibliographic Details
Published inBMC surgery Vol. 22; no. 1; pp. 1 - 310
Main Authors Eghbali, Foolad, Bahardoust, Mansour, Pazouki, Abdolreza, Barahman, Gelayol, Tizmaghz, Adnan, Hajmohammadi, Amir, Karami, Reza, Hosseini-Baharanchi, Fatemeh Sadat
Format Journal Article
LanguageEnglish
Published London BioMed Central Ltd 11.08.2022
BioMed Central
BMC
Subjects
Age
Bariatric surgery
Blood pressure
Body weight loss
Comorbidity
Comparative analysis
Diabetes
Diabetes mellitus
Diabetics
Gastric bypass
Gastrointestinal surgery
Hypertension
Hypothyroidism
Laparoscopy
Medical research
Medicine, Experimental
Obesity
Patients
Roux-en-Y gastric bypass
Surgery
Sutures
Type 2 diabetes
Weight control
Weight loss
Online AccessGet full text

Cover

Abstract Abstract Background Historically, Roux-en-Y gastric bypass (RYGB) has been considered the gold standard of bariatric surgery (BS). This procedure acts as a mixed restrictive and malabsorptive operation. Methods  This retrospective cohort study included 410 morbidly obese patients (BMI > 40 kg/m 2 or BMI > 35 kg/m 2  along with at least one major comorbidity) who underwent primary laparoscopic RYGB surgery from 2009 to 2015 by a single surgery team. The patients were 18 years and older with at least 12 months of follow-up. Total weight loss (%TWL) and comorbidity resolution were compared in short-term (12 months) and mid-term (12–60 months) follow-ups. The primary and secondary outcomes were evaluating the effect of Roux-en-Y on weight loss and control of comorbidities, respectively. Results  The mean ± SD age, weight, and BMI at surgery were 40.1 ± 10.58 years, 123.32 ± 19.88 kg, and 45.78 ± 5.54 kg/m 2 , respectively, and 329 (80%) were female, and 62 (15%) had T2DM. %TWL was significantly higher in T2DM patients 9 months postoperatively and after that. Patients with lower BMI (< 50 kg/m 2 ) at surgery and non-diabetic patients had a significantly lower %TWL over a short- and long-term follow-up (P < 0.001). Conclusions BS remains the most efficacious and durable weight loss treatment. However, a proportion of patients will experience insufficient weight loss following BS.
AbstractList Historically, Roux-en-Y gastric bypass (RYGB) has been considered the gold standard of bariatric surgery (BS). This procedure acts as a mixed restrictive and malabsorptive operation. This retrospective cohort study included 410 morbidly obese patients (BMI > 40 kg/m.sup.2 or BMI > 35 kg/m.sup.2 along with at least one major comorbidity) who underwent primary laparoscopic RYGB surgery from 2009 to 2015 by a single surgery team. The patients were 18 years and older with at least 12 months of follow-up. Total weight loss (%TWL) and comorbidity resolution were compared in short-term (12 months) and mid-term (12-60 months) follow-ups. The primary and secondary outcomes were evaluating the effect of Roux-en-Y on weight loss and control of comorbidities, respectively. The mean [+ or -] SD age, weight, and BMI at surgery were 40.1 [+ or -] 10.58 years, 123.32 [+ or -] 19.88 kg, and 45.78 [+ or -] 5.54 kg/m.sup.2, respectively, and 329 (80%) were female, and 62 (15%) had T2DM. %TWL was significantly higher in T2DM patients 9 months postoperatively and after that. Patients with lower BMI (< 50 kg/m.sup.2) at surgery and non-diabetic patients had a significantly lower %TWL over a short- and long-term follow-up (P < 0.001). BS remains the most efficacious and durable weight loss treatment. However, a proportion of patients will experience insufficient weight loss following BS.
Background Historically, Roux-en-Y gastric bypass (RYGB) has been considered the gold standard of bariatric surgery (BS). This procedure acts as a mixed restrictive and malabsorptive operation. Methods This retrospective cohort study included 410 morbidly obese patients (BMI > 40 kg/m2 or BMI > 35 kg/m2 along with at least one major comorbidity) who underwent primary laparoscopic RYGB surgery from 2009 to 2015 by a single surgery team. The patients were 18 years and older with at least 12 months of follow-up. Total weight loss (%TWL) and comorbidity resolution were compared in short-term (12 months) and mid-term (12–60 months) follow-ups. The primary and secondary outcomes were evaluating the effect of Roux-en-Y on weight loss and control of comorbidities, respectively. Results The mean ± SD age, weight, and BMI at surgery were 40.1 ± 10.58 years, 123.32 ± 19.88 kg, and 45.78 ± 5.54 kg/m2, respectively, and 329 (80%) were female, and 62 (15%) had T2DM. %TWL was significantly higher in T2DM patients 9 months postoperatively and after that. Patients with lower BMI (< 50 kg/m2) at surgery and non-diabetic patients had a significantly lower %TWL over a short- and long-term follow-up (P < 0.001). Conclusions BS remains the most efficacious and durable weight loss treatment. However, a proportion of patients will experience insufficient weight loss following BS.
Abstract Background Historically, Roux-en-Y gastric bypass (RYGB) has been considered the gold standard of bariatric surgery (BS). This procedure acts as a mixed restrictive and malabsorptive operation. Methods  This retrospective cohort study included 410 morbidly obese patients (BMI > 40 kg/m2 or BMI > 35 kg/m2 along with at least one major comorbidity) who underwent primary laparoscopic RYGB surgery from 2009 to 2015 by a single surgery team. The patients were 18 years and older with at least 12 months of follow-up. Total weight loss (%TWL) and comorbidity resolution were compared in short-term (12 months) and mid-term (12–60 months) follow-ups. The primary and secondary outcomes were evaluating the effect of Roux-en-Y on weight loss and control of comorbidities, respectively. Results  The mean ± SD age, weight, and BMI at surgery were 40.1 ± 10.58 years, 123.32 ± 19.88 kg, and 45.78 ± 5.54 kg/m2, respectively, and 329 (80%) were female, and 62 (15%) had T2DM. %TWL was significantly higher in T2DM patients 9 months postoperatively and after that. Patients with lower BMI (< 50 kg/m2) at surgery and non-diabetic patients had a significantly lower %TWL over a short- and long-term follow-up (P < 0.001). Conclusions BS remains the most efficacious and durable weight loss treatment. However, a proportion of patients will experience insufficient weight loss following BS.
Background Historically, Roux-en-Y gastric bypass (RYGB) has been considered the gold standard of bariatric surgery (BS). This procedure acts as a mixed restrictive and malabsorptive operation. Methods This retrospective cohort study included 410 morbidly obese patients (BMI > 40 kg/m.sup.2 or BMI > 35 kg/m.sup.2 along with at least one major comorbidity) who underwent primary laparoscopic RYGB surgery from 2009 to 2015 by a single surgery team. The patients were 18 years and older with at least 12 months of follow-up. Total weight loss (%TWL) and comorbidity resolution were compared in short-term (12 months) and mid-term (12-60 months) follow-ups. The primary and secondary outcomes were evaluating the effect of Roux-en-Y on weight loss and control of comorbidities, respectively. Results The mean [+ or -] SD age, weight, and BMI at surgery were 40.1 [+ or -] 10.58 years, 123.32 [+ or -] 19.88 kg, and 45.78 [+ or -] 5.54 kg/m.sup.2, respectively, and 329 (80%) were female, and 62 (15%) had T2DM. %TWL was significantly higher in T2DM patients 9 months postoperatively and after that. Patients with lower BMI (< 50 kg/m.sup.2) at surgery and non-diabetic patients had a significantly lower %TWL over a short- and long-term follow-up (P < 0.001). Conclusions BS remains the most efficacious and durable weight loss treatment. However, a proportion of patients will experience insufficient weight loss following BS. Keywords: Roux-en-Y gastric bypass, Weight loss, Bariatric surgery
BACKGROUNDHistorically, Roux-en-Y gastric bypass (RYGB) has been considered the gold standard of bariatric surgery (BS). This procedure acts as a mixed restrictive and malabsorptive operation. METHODS This retrospective cohort study included 410 morbidly obese patients (BMI > 40 kg/m2 or BMI > 35 kg/m2 along with at least one major comorbidity) who underwent primary laparoscopic RYGB surgery from 2009 to 2015 by a single surgery team. The patients were 18 years and older with at least 12 months of follow-up. Total weight loss (%TWL) and comorbidity resolution were compared in short-term (12 months) and mid-term (12-60 months) follow-ups. The primary and secondary outcomes were evaluating the effect of Roux-en-Y on weight loss and control of comorbidities, respectively. RESULTS The mean ± SD age, weight, and BMI at surgery were 40.1 ± 10.58 years, 123.32 ± 19.88 kg, and 45.78 ± 5.54 kg/m2, respectively, and 329 (80%) were female, and 62 (15%) had T2DM. %TWL was significantly higher in T2DM patients 9 months postoperatively and after that. Patients with lower BMI (< 50 kg/m2) at surgery and non-diabetic patients had a significantly lower %TWL over a short- and long-term follow-up (P < 0.001). CONCLUSIONSBS remains the most efficacious and durable weight loss treatment. However, a proportion of patients will experience insufficient weight loss following BS.
Abstract Background Historically, Roux-en-Y gastric bypass (RYGB) has been considered the gold standard of bariatric surgery (BS). This procedure acts as a mixed restrictive and malabsorptive operation. Methods  This retrospective cohort study included 410 morbidly obese patients (BMI > 40 kg/m 2 or BMI > 35 kg/m 2  along with at least one major comorbidity) who underwent primary laparoscopic RYGB surgery from 2009 to 2015 by a single surgery team. The patients were 18 years and older with at least 12 months of follow-up. Total weight loss (%TWL) and comorbidity resolution were compared in short-term (12 months) and mid-term (12–60 months) follow-ups. The primary and secondary outcomes were evaluating the effect of Roux-en-Y on weight loss and control of comorbidities, respectively. Results  The mean ± SD age, weight, and BMI at surgery were 40.1 ± 10.58 years, 123.32 ± 19.88 kg, and 45.78 ± 5.54 kg/m 2 , respectively, and 329 (80%) were female, and 62 (15%) had T2DM. %TWL was significantly higher in T2DM patients 9 months postoperatively and after that. Patients with lower BMI (< 50 kg/m 2 ) at surgery and non-diabetic patients had a significantly lower %TWL over a short- and long-term follow-up (P < 0.001). Conclusions BS remains the most efficacious and durable weight loss treatment. However, a proportion of patients will experience insufficient weight loss following BS.
ArticleNumber 310
Audience Academic
Author Eghbali, Foolad
Barahman, Gelayol
Pazouki, Abdolreza
Bahardoust, Mansour
Tizmaghz, Adnan
Hajmohammadi, Amir
Hosseini-Baharanchi, Fatemeh Sadat
Karami, Reza
Author_xml – sequence: 1
  givenname: Foolad
  surname: Eghbali
  fullname: Eghbali, Foolad
– sequence: 2
  givenname: Mansour
  surname: Bahardoust
  fullname: Bahardoust, Mansour
– sequence: 3
  givenname: Abdolreza
  surname: Pazouki
  fullname: Pazouki, Abdolreza
– sequence: 4
  givenname: Gelayol
  surname: Barahman
  fullname: Barahman, Gelayol
– sequence: 5
  givenname: Adnan
  surname: Tizmaghz
  fullname: Tizmaghz, Adnan
– sequence: 6
  givenname: Amir
  surname: Hajmohammadi
  fullname: Hajmohammadi, Amir
– sequence: 7
  givenname: Reza
  surname: Karami
  fullname: Karami, Reza
– sequence: 8
  givenname: Fatemeh Sadat
  surname: Hosseini-Baharanchi
  fullname: Hosseini-Baharanchi, Fatemeh Sadat
BookMark eNptkktrVDEUxy9SsQ_9Aq4CbtzcmudNrguhFB-FgiK6cBXyOJnJeOdmTDLVfnsznaKOlBASTv7nd3KS_2l3NKcZuu45weeEqOFVIVSNrMeU9pjIAffsUXdCuCQ95Yoe_bM_7k5LWeGmUkI86Y6ZGAWTozzpvn_K4KOrKRcUUkY_IS6WFU2pFGRChYw-p-2vHub-G1qYUnN0yN5uTCmvUV0Cqhlmj8xulpJcNBU8CuZB4NPucTBTgWf361n39d3bL5cf-uuP768uL657xyWuPVhgTjgeBoktBi4kHYZ2XaqEHb0xGHPmpMdgxeiFDJZwrrgD4Yx0FgI76672XJ_MSm9yXJt8q5OJ-i6Q8kKbXKObQENw1oOzgxEDF2q0WJIwuvY-SkkPorHe7FmbrV2DdzDXbKYD6OHJHJd6kW70yAZJ-NgAL-8BOf3YQql6HYuDaTIzpG3RVGJKRqoob9IX_0lXaZvn9lQ7FRva3zH2V7UwrYE4h9Tquh1UX0jCJBaK7sqeP6Bqw8M6uuajEFv8IIHuE1xuX5Uh_OmRYL2zm97bTTe76Tu7acZ-A8-fyIs
CitedBy_id crossref_primary_10_3390_nu16071071
crossref_primary_10_4103_sjo_sjo_8_22
crossref_primary_10_1097_JS9_0000000000000330
crossref_primary_10_7570_jomes23008
Cites_doi 10.1097/00000658-199509000-00011
10.1381/096089206778392284
10.1007/s11695-018-3610-4
10.1007/s00464-005-0115-8
10.1007/s11695-009-9923-6
10.1007/s11695-018-3450-2
10.1007/s11695-008-9540-9
10.7326/0003-4819-155-5-201109060-00005
10.1097/01.sla.0000217592.04061.d5
10.1381/096089200321668659
10.1007/s11695-009-9895-6
10.1381/096089200321643511
10.1007/s11695-011-0420-3
10.1111/joim.12012
10.1007/s11695-015-2022-y
10.1007/s00464-019-07106-0
10.1016/j.cgh.2010.11.004
10.1016/j.soard.2010.10.019
10.1007/s11695-021-05394-x
10.1016/j.ciresp.2019.09.008
10.1136/bmjopen-2020-046407
10.1016/j.surg.2006.07.002
10.1016/j.soard.2006.11.006
10.1007/s11695-021-05555-y
10.1007/s13304-020-00961-w
10.1080/00015458.2018.1433797
10.1016/j.soard.2018.03.012
10.1007/s11695-021-05580-x
10.1007/s11695-017-3059-x
10.3389/fendo.2022.867838
ContentType Journal Article
Copyright COPYRIGHT 2022 BioMed Central Ltd.
2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2022
Copyright_xml – notice: COPYRIGHT 2022 BioMed Central Ltd.
– notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2022
DBID AAYXX
CITATION
3V.
7QO
7QP
7X7
7XB
88E
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FR3
FYUFA
GHDGH
K9.
M0S
M1P
P64
PIMPY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.1186/s12893-022-01760-3
DatabaseName CrossRef
ProQuest Central (Corporate)
Biotechnology Research Abstracts
Calcium & Calcified Tissue Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
AUTh Library subscriptions: ProQuest Central
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Biotechnology and BioEngineering Abstracts
ProQuest - Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
Technology Research Database
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
Biotechnology Research Abstracts
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database


MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: BENPR
  name: AUTh Library subscriptions: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
EISSN 1471-2482
EndPage 310
ExternalDocumentID oai_doaj_org_article_efcbdecb6a564589b071f9c359887de5
A713705829
10_1186_s12893_022_01760_3
GroupedDBID ---
-A0
0R~
23N
2WC
3V.
53G
5GY
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AAWTL
AAYXX
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACPRK
ACRMQ
ADBBV
ADINQ
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
EMB
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
UKHRP
W2D
WOQ
WOW
XSB
ABVAZ
AFGXO
AFNRJ
7QO
7QP
7XB
8FD
8FK
AZQEC
DWQXO
FR3
K9.
P64
PQEST
PQUKI
7X8
5PM
ID FETCH-LOGICAL-c470t-ebe3c5c4f670b0e457266537285b9daa0043c7d0eb59d57fb14484ce5ca7cbef3
IEDL.DBID RPM
ISSN 1471-2482
IngestDate Thu Sep 05 15:26:21 EDT 2024
Tue Sep 17 20:52:59 EDT 2024
Fri Aug 16 04:48:28 EDT 2024
Sat Aug 31 00:21:45 EDT 2024
Thu Feb 22 23:58:25 EST 2024
Wed Jan 10 04:11:28 EST 2024
Thu Sep 12 17:16:31 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c470t-ebe3c5c4f670b0e457266537285b9daa0043c7d0eb59d57fb14484ce5ca7cbef3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367149/
PMID 35953797
PQID 2703685533
PQPubID 42548
ParticipantIDs doaj_primary_oai_doaj_org_article_efcbdecb6a564589b071f9c359887de5
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9367149
proquest_miscellaneous_2702192824
proquest_journals_2703685533
gale_infotracmisc_A713705829
gale_infotracacademiconefile_A713705829
crossref_primary_10_1186_s12893_022_01760_3
PublicationCentury 2000
PublicationDate 2022-08-11
PublicationDateYYYYMMDD 2022-08-11
PublicationDate_xml – month: 08
  year: 2022
  text: 2022-08-11
  day: 11
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle BMC surgery
PublicationYear 2022
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References N Slagter (1760_CR5) 2021; 31
KB Jones (1760_CR21) 2000; 10
DE Hogling (1760_CR16) 2018; 14
RS Alami (1760_CR30) 2007; 3
JC Gould (1760_CR31) 2006; 140
MJ Luesma (1760_CR3) 2022; 13
L Angrisani (1760_CR1) 2018; 28
L Sjöström (1760_CR4) 2013; 273
R Corcelles (1760_CR13) 2016; 26
K Higa (1760_CR12) 2011; 7
P Major (1760_CR18) 2018; 118
WS Júnior (1760_CR27) 2011; 21
R Lutfi (1760_CR17) 2006; 20
T Rutledge (1760_CR11) 2011; 21
S Alger-Mayer (1760_CR29) 2009; 19
TT Søvik (1760_CR7) 2011; 155
V Vázquez-Velázquez (1760_CR19) 2018; 28
WJ Pories (1760_CR22) 1995; 222
AW van de Laar (1760_CR14) 2021; 31
M Brissman (1760_CR6) 2021; 11
BKA Dayyeh (1760_CR9) 2011; 9
N Dugan (1760_CR28) 2020; 34
DS Bonouvrie (1760_CR8) 2019; 29
M Kermansaravi (1760_CR2) 2021; 73
HJ Sugerman (1760_CR23) 2003; 237
DS Bonouvrie (1760_CR20) 2019; 29
J Odom (1760_CR10) 2010; 20
A-S Van Rijswijk (1760_CR15) 2021; 31
AC Wittgrove (1760_CR32) 2000; 10
NV Christou (1760_CR24) 2006; 244
Y Ma (1760_CR25) 2006; 16
FS Pereferrer (1760_CR26) 2020; 98
References_xml – volume: 222
  start-page: 339
  issue: 3
  year: 1995
  ident: 1760_CR22
  publication-title: Ann Surg
  doi: 10.1097/00000658-199509000-00011
  contributor:
    fullname: WJ Pories
– volume: 16
  start-page: 1227
  issue: 9
  year: 2006
  ident: 1760_CR25
  publication-title: Obes Surg
  doi: 10.1381/096089206778392284
  contributor:
    fullname: Y Ma
– volume: 29
  start-page: 691
  issue: 2
  year: 2019
  ident: 1760_CR8
  publication-title: Obes Surg
  doi: 10.1007/s11695-018-3610-4
  contributor:
    fullname: DS Bonouvrie
– volume: 20
  start-page: 864
  issue: 6
  year: 2006
  ident: 1760_CR17
  publication-title: Surg Endosc Other Interv Tech
  doi: 10.1007/s00464-005-0115-8
  contributor:
    fullname: R Lutfi
– volume: 21
  start-page: 29
  issue: 1
  year: 2011
  ident: 1760_CR11
  publication-title: Obes Surg
  doi: 10.1007/s11695-009-9923-6
  contributor:
    fullname: T Rutledge
– volume: 29
  start-page: 691
  issue: 2
  year: 2019
  ident: 1760_CR20
  publication-title: Obes Surg
  doi: 10.1007/s11695-018-3610-4
  contributor:
    fullname: DS Bonouvrie
– volume: 28
  start-page: 3783
  issue: 12
  year: 2018
  ident: 1760_CR1
  publication-title: Obes Surg
  doi: 10.1007/s11695-018-3450-2
  contributor:
    fullname: L Angrisani
– volume: 19
  start-page: 139
  issue: 2
  year: 2009
  ident: 1760_CR29
  publication-title: Obes Surg
  doi: 10.1007/s11695-008-9540-9
  contributor:
    fullname: S Alger-Mayer
– volume: 155
  start-page: 281
  issue: 5
  year: 2011
  ident: 1760_CR7
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-155-5-201109060-00005
  contributor:
    fullname: TT Søvik
– volume: 244
  start-page: 734
  issue: 5
  year: 2006
  ident: 1760_CR24
  publication-title: Ann Surg
  doi: 10.1097/01.sla.0000217592.04061.d5
  contributor:
    fullname: NV Christou
– volume: 10
  start-page: 183
  issue: 2
  year: 2000
  ident: 1760_CR21
  publication-title: Obes Surg
  doi: 10.1381/096089200321668659
  contributor:
    fullname: KB Jones
– volume: 20
  start-page: 349
  issue: 3
  year: 2010
  ident: 1760_CR10
  publication-title: Obes Surg
  doi: 10.1007/s11695-009-9895-6
  contributor:
    fullname: J Odom
– volume: 10
  start-page: 233
  issue: 3
  year: 2000
  ident: 1760_CR32
  publication-title: Obes Surg
  doi: 10.1381/096089200321643511
  contributor:
    fullname: AC Wittgrove
– volume: 21
  start-page: 1724
  issue: 11
  year: 2011
  ident: 1760_CR27
  publication-title: Obes Surg
  doi: 10.1007/s11695-011-0420-3
  contributor:
    fullname: WS Júnior
– volume: 273
  start-page: 219
  issue: 3
  year: 2013
  ident: 1760_CR4
  publication-title: J Intern Med
  doi: 10.1111/joim.12012
  contributor:
    fullname: L Sjöström
– volume: 26
  start-page: 1794
  issue: 8
  year: 2016
  ident: 1760_CR13
  publication-title: Obes Surg
  doi: 10.1007/s11695-015-2022-y
  contributor:
    fullname: R Corcelles
– volume: 34
  start-page: 3574
  issue: 8
  year: 2020
  ident: 1760_CR28
  publication-title: Surg Endosc
  doi: 10.1007/s00464-019-07106-0
  contributor:
    fullname: N Dugan
– volume: 9
  start-page: 228
  issue: 3
  year: 2011
  ident: 1760_CR9
  publication-title: Clin Gastroenterol Hepatol
  doi: 10.1016/j.cgh.2010.11.004
  contributor:
    fullname: BKA Dayyeh
– volume: 7
  start-page: 516
  issue: 4
  year: 2011
  ident: 1760_CR12
  publication-title: Surg Obes Relat Dis
  doi: 10.1016/j.soard.2010.10.019
  contributor:
    fullname: K Higa
– volume: 31
  start-page: 3833
  issue: 8
  year: 2021
  ident: 1760_CR15
  publication-title: Obes Surg
  doi: 10.1007/s11695-021-05394-x
  contributor:
    fullname: A-S Van Rijswijk
– volume: 98
  start-page: 72
  issue: 2
  year: 2020
  ident: 1760_CR26
  publication-title: Cir Esp
  doi: 10.1016/j.ciresp.2019.09.008
  contributor:
    fullname: FS Pereferrer
– volume: 11
  issue: 3
  year: 2021
  ident: 1760_CR6
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2020-046407
  contributor:
    fullname: M Brissman
– volume: 140
  start-page: 524
  issue: 4
  year: 2006
  ident: 1760_CR31
  publication-title: Surgery
  doi: 10.1016/j.surg.2006.07.002
  contributor:
    fullname: JC Gould
– volume: 3
  start-page: 141
  issue: 2
  year: 2007
  ident: 1760_CR30
  publication-title: Surg Obes Relat Dis
  doi: 10.1016/j.soard.2006.11.006
  contributor:
    fullname: RS Alami
– volume: 31
  start-page: 4236
  issue: 10
  year: 2021
  ident: 1760_CR5
  publication-title: Obes Surg
  doi: 10.1007/s11695-021-05555-y
  contributor:
    fullname: N Slagter
– volume: 73
  start-page: 663
  issue: 2
  year: 2021
  ident: 1760_CR2
  publication-title: Updat Surg
  doi: 10.1007/s13304-020-00961-w
  contributor:
    fullname: M Kermansaravi
– volume: 118
  start-page: 307
  issue: 5
  year: 2018
  ident: 1760_CR18
  publication-title: Acta Chir Belg
  doi: 10.1080/00015458.2018.1433797
  contributor:
    fullname: P Major
– volume: 14
  start-page: 936
  issue: 7
  year: 2018
  ident: 1760_CR16
  publication-title: Surg Obes Relat Dis
  doi: 10.1016/j.soard.2018.03.012
  contributor:
    fullname: DE Hogling
– volume: 31
  start-page: 4607
  issue: 10
  year: 2021
  ident: 1760_CR14
  publication-title: Obes Surg
  doi: 10.1007/s11695-021-05580-x
  contributor:
    fullname: AW van de Laar
– volume: 28
  start-page: 864
  issue: 3
  year: 2018
  ident: 1760_CR19
  publication-title: Obes Surg
  doi: 10.1007/s11695-017-3059-x
  contributor:
    fullname: V Vázquez-Velázquez
– volume: 13
  start-page: 867838
  year: 2022
  ident: 1760_CR3
  publication-title: Front Endocrinol
  doi: 10.3389/fendo.2022.867838
  contributor:
    fullname: MJ Luesma
– volume: 237
  start-page: 751
  issue: 6
  year: 2003
  ident: 1760_CR23
  publication-title: Ann Surg
  contributor:
    fullname: HJ Sugerman
SSID ssj0017855
Score 2.3502007
Snippet Abstract Background Historically, Roux-en-Y gastric bypass (RYGB) has been considered the gold standard of bariatric surgery (BS). This procedure acts as a...
Background Historically, Roux-en-Y gastric bypass (RYGB) has been considered the gold standard of bariatric surgery (BS). This procedure acts as a mixed...
Historically, Roux-en-Y gastric bypass (RYGB) has been considered the gold standard of bariatric surgery (BS). This procedure acts as a mixed restrictive and...
BACKGROUNDHistorically, Roux-en-Y gastric bypass (RYGB) has been considered the gold standard of bariatric surgery (BS). This procedure acts as a mixed...
Abstract Background Historically, Roux-en-Y gastric bypass (RYGB) has been considered the gold standard of bariatric surgery (BS). This procedure acts as a...
SourceID doaj
pubmedcentral
proquest
gale
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
StartPage 1
SubjectTerms Age
Bariatric surgery
Blood pressure
Body weight loss
Comorbidity
Comparative analysis
Diabetes
Diabetes mellitus
Diabetics
Gastric bypass
Gastrointestinal surgery
Hypertension
Hypothyroidism
Laparoscopy
Medical research
Medicine, Experimental
Obesity
Patients
Roux-en-Y gastric bypass
Surgery
Sutures
Type 2 diabetes
Weight control
Weight loss
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NaxUxEA_SkxdRVFxtJYLgQUL35TveqliKBxGxUE8hmWRVlH2lfQ_1v3cmu69068GLh71ssrvZmcxXMvkNY89VXwxG_1moFJLQwa6ET-CFpVX9vhDAeMvyfW9PTvW7M3N2rdQX5YRN8MAT4Q7rALlUyDYR7okPGW3iEICA57wrdUIvXZldMDXvHzhvzO6IjLeHl6iFKU9NUhqCs6h5FmaoofX_rZNv5kleMzzHd9md2WPkR9NI77FbdbzPvn-4oB0WKpXD0e3kP9sKJ_-B3-Kt7Df_uN7-EnUUn_mXRLU5gOff5-gpv-Lo8vENpcLyRNfMn1r4XHvn5gsfsNPjt5_enIi5boIA7fqNQL4oMKAH6_rcV20cWmGjnPQmh5IS7f6BK33NJhTjhoxBlddQDSQHuQ7qIdsb12N9xLgsA0BN0uastSZsM7AKapAuJKVk7tjLHRnj-QSPEVtY4W2ciB6R6LERPaqOvSZKX_UkaOt2AxkeZ4bHfzG8Yy-IT5EEELkCaT5HgAMmKKt4hGG3642XoWP7i54oOLBs3nE6zoJ7GSUBkuHkUTjYZ1fN9CQlo411vW19UM9jrKo75hYzZPFny5bx29cG3h2UdRiVPv4fpHjCbss2p71YrfbZ3uZiWw_QR9rkp00c_gDyBRD7
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: AUTh Library subscriptions: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3daxQxEA-1ffFFFBVXq0QQfJDl9vIdX6SVlsOHUoqF-hTytVWU3fN6h_rfO5PbPd0KPuzLJtmPmclkJjP5DSGveJMkeP-h5t76Wlg1r42Ppla4q98kBBgvWb5nanEpPlzJqz2yGM_CYFrlqBOLok59xD3yGUOkKCPBOpn5gLsAcT17t_xeY_0ojLMOxTTukAM2FxiwPTg-OTu_2EUUNIwdD80YNbsBvYyZawwTE7QCXTRZmAp-_79a-nbm5F9L0el9cm-wIenRlukPyF7uHpKv5yuMuWDxHAqGKP1R9jzpN3gXLYXA6UW_-Vnnrv5Erz1W64g0_FqC7fyWghFI15gcSz1eA8dyokM1ntsPfEQuT08-vl_UQyWFOgrdrGvgFI8yilbpJjRZSA3rsuSaGRls8h7jgVGnJgdpk9RtADfLiJhl9DqG3PLHZL_ru_yEUJbaGLNnKgQhBKKdRcVjtkxbzzkLFXkzktEtt4AZrjgaRrkt0R0Q3RWiO16RY6T0rieCXZcb_eraDXPH5TaGlGNQHqFvjA1gFrU2Ivag0SnLirxGPjmckigYfjhZAB-M4FbuCBxx3UjDbEUOJz1hKsVp88hpN0zlG_dH8CrycteMIzE9rcv9pvQBzQ_eq6iInkjI5M-mLd2XzwXO23KlwU99-v-XPyN3WZFWcPrnh2R_vdrk52APrcOLQdR_AxfrDI0
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NaxQxFA-1XryIouJolQiCB4nO5juCSBVLERQRF-op5GtasczW7S62_73vZWeqU3vxMJdJZibzvvJe8vJ7hDwVbVYQ_UcmggtMOj1jNiTLNK7qtxkBxmuW7ye9P5cfDtTBFhnLHQ0EPL0ytMN6UvPl8Yuzn-dvQOFfV4W3-uUp2FjMQuOYZGA02JVr5DqXQqLEf5R_dhWMrVVQZ2CQGZeWj4dornzHZKKqeP7_Wu3LmZR_TU17t8jNwaekuxshuE22Sn-H_Pi8xD0YLKZDwTGlv-oaKD2Gb9FaGJx-WazPWOnZN3oYsHpHovH8BHzpVxScQrrCZFka8Bo4WDIdqvNcfuFdMt97__XdPhsqK7AkTbtiwDmRVJKdNm1si1QG5mklDLcquhwC7g8mk9sSlcvKdBHCLitTUSmYFEsn7pHtftGX-4Ty3KVUAtcxSikR_SxpkYrjxgUheGzI85GM_mQDoOFr4GG13xDdA9F9JboXDXmLlL7oieDX9cZieegHXfKlSzGXFHVAKBzrIrhJnUuIRWhNLqohz5BPHoUGuJLCcNIABoxgV34XAnPTKstdQ3YmPUG10rR55LQfJdNzhCwDQRIw2CcXzfgkpqv1ZbGufWAmgGhWNsRMJGTyZ9OW_vtRhfd2QhuIWx_8F-Eekhu8Cq9ls9kO2V4t1-URuEur-LjqwG9-EhBC
  priority: 102
  providerName: Scholars Portal
Title Predictors for weight loss after Roux-en-Y gastric bypass: the trend and associated factors for weight loss
URI https://www.proquest.com/docview/2703685533/abstract/
https://search.proquest.com/docview/2702192824
https://pubmed.ncbi.nlm.nih.gov/PMC9367149
https://doaj.org/article/efcbdecb6a564589b071f9c359887de5
Volume 22
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NaxQxFA9tBelFFBVH6xJB8CDpzk6-vbWlpQgtS7GwnkKSydRiO7tsd1H_e9_LzpROvXmYOUwyM8n7SN5LXn6PkI-8rCV4_4Fxbz0TVk2Y8dEwhav6ZY0A4znK91ydXoqvMznbIrI_C5OD9mO43m9vbvfb6x85tnJxG8d9nNh4enZkudJg2Y-3ybbmvHfRu60DbaTsT8cYNb6DARhD1CqMQNAKBp1d8hRPo3KNQE8PJqOM2f_vyPw4WvLB9HPynDzr7EZ6sGnfC7KV2pfk53SJ-yyYMIeC8Ul_5XVOegP_ojn5N72Yr3-z1LLv9Mpjho5Iw58F2MtfKBh-dIUBsdTj1XEp1bTLwPP4g6_I5cnxt6NT1mVPYFHocsWAOzzKKBqly1AmITXMxdDryshga-9xDzDqukxB2lrqJoBrZURMMnodQ2r4a7LTztv0htCqbmJMvlIhCCEQ4SwqHpOttPWcV6Egn3syusUGJMNl58Iot6G_A_q7TH_HC3KIlL6viQDX-cF8eeU6NrvUxFCnGJRHuBtjA5hCjY2IN2h0nWRBPiGfHKohcCX67jQBNBgBrdwBON-6lKayBdkb1AT1icPintOuU987VyEsGcgRh8Z-uC_GNzEkrU3zda4Doz14rKIgeiAhg54NS0CiM4R3J8Fv__vNd2S3yjJt2GSyR3ZWy3V6D-bRKoxAKWZ6RJ4cHp9PL0Z5kQHuZ8KMsqL8BRyEFNQ
link.rule.ids 230,315,733,786,790,870,891,2115,12083,21416,24346,27957,27958,31754,31755,33779,33780,43345,43840,53827,53829
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZge4BLBQJEaAEjIXFAUdP4GS6oRa0WKKuqaqVysvxKi0DJsg8B_54Zr3chReKQS2znMS_P2ONvCHnJqiAg-ncls40teSP3S229LiWu6lcBAcZTlu9Eji_4h0txmRfc5jmtcm0Tk6EOvcc18r0akaK0AO_k7fR7iVWjcHc1l9C4TbY4g1BlRLYOjyanZ5t9BAUj1kdltNybgzXGfLUa0xGUBAs0mI4Sav-_tvlmvuRfE9DxPbKdPUd6sGL1fXIrdg_I19MZ7rRgyRwK7if9kVY66Td4F03lv-lZv_xZxq78TK8s1ujw1P2agsf8hoLrRxeYEkstXplPMdBcg-fmAx-Si-Oj83fjMtdPKD1X1aIE_jAvPG-lqlwVuVAwGwumai1cE6zFXUCvQhWdaIJQrYPgSnMfhbfKu9iyR2TU9V18TGgdWu-jraVznHPEOPOS-djUqrGM1a4gr9dkNNMVTIZJ4YWWZkV0A0Q3ieiGFeQQKb3piRDX6UY_uzJZY0xsvQvRO2kR8EY3DpyhtvGIOKhViKIgr5BPBhURuOJtPk8AH4yQVuYAwm9VCV03Bdkd9AQF8sPmNadNVuC5-SNuBXmxacaRmJTWxX6Z-oC9h5iVF0QNJGTwZ8OW7st1AvFumFQQnT75_8ufkzvj808n5uT95OMOuVsnyYWwf3-XjBazZXwKHtHCPcti_xso5gvA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagSFUvPASIQAEjIXFA2WTj2E64lcKqvKoVolLhYtkTp1Rts6ttVjx-PTPepNostx5yiZ3I9szYM_bnbxh7KdJKYvTvYmFLG-elGseFhSJWtKufVkQwHlC-h-rgKP94LI_XUn0F0D6401FzfjFqTn8GbOX8ApIeJ5ZMv-yXQmn07JN5VSc32S202azsA_XuAEEXUvZ3ZAqVXOI0TEC1jHAIWuHUs8O26U6q0ET3tLYkBeb-_-fnTczk2iI0ucN-9M1fYU_ORsvWjeDvBrPjtfp3l93uXFO-t6pyj93wzX12Nl3QUQ7l5OHo3_JfYSuVn2NHeMgvzr_Olr9j38Tf-YmlJCDA3Z85uuRvOPqWvCXMLbf0dIrgK94l-dn84QN2NHn_bf8g7hI0xJDrtI1RAQRIyGulU5f6XGpc7nFIs0K6srKWjhlBV6l3sqykrh1Gb0UOXoLV4HwtHrKtZtb4R4xnVQ3gbaacy_OcSNRACfBlpksrROYi9rqXkZmveDhMiF8KZVbCNShcE4RrRMTekhivahKHdngxW5yYbqSNr8FVHpyyxKhTlA69rboEojQsdOVlxF6REhiydBQ52O7CAjaYOLPMHsb3OpWoexHbHdREC4Vhca9GppshLk1GzGeopAIb--KqmL4k1FvjZ8tQBxcUDIrziOmB-g16NixBpQos4Z0SPb72l8_Z9vTdxHz-cPjpCdvJgu0U8Xi8y7baxdI_RWesdc-C2f0DP4w1Aw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Predictors+for+weight+loss+after+Roux-en-Y+gastric+bypass%3A+the+trend+and+associated+factors+for+weight+loss&rft.jtitle=BMC+surgery&rft.au=Eghbali%2C+Foolad&rft.au=Bahardoust%2C+Mansour&rft.au=Pazouki%2C+Abdolreza&rft.au=Barahman%2C+Gelayol&rft.date=2022-08-11&rft.issn=1471-2482&rft.eissn=1471-2482&rft.volume=22&rft.issue=1&rft_id=info:doi/10.1186%2Fs12893-022-01760-3&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12893_022_01760_3
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2482&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2482&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2482&client=summon